Menu
Not yet recruiting NCT07495228

Cognitive Processing Therapy for Childbirth-Related Post-Traumatic Stress Disorder

No phase Interventional Childbirth-Related Posttraumatic Stress Disorder Childbirth-related Trauma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Individual Cognitive Processing Therapy.
Who it may be relevant to
Registry conditions: Childbirth-Related Posttraumatic Stress Disorder, Childbirth-related Trauma. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to determine whether participation in an individual 8-session cognitive processing therapy (CPT) is feasible, acceptable, and leads to clinically meaningful trauma symptom reduction in individuals experiencing childbirth-related trauma. The main questions it aims to answer are: 1. Is it feasible for women and birthing people to attend and complete an 8-session course of CPT delivered virtually within a specialized women's mental health clinic? 2. Do participants find this modified 8-session CPT protocol acceptable and helpful? 3. Does the treatment lead to clinically meaningful reductions in childbirth-related posttraumatic stress and related symptoms? Participants will be asked to: 1. Attend 8 weekly sessions of individual CPT for childbirth-related trauma 2. Complete a self-report measure of trauma symptoms weekly (i.e., the PCL-5) 3. Complete additional symptom questionnaires at baseline, post-treatment, and at one-month follow-up. 4. Complete a brief qualitative interview one week after treatment to share feedback on their experience

Interventions

  • Behavioral Individual Cognitive Processing Therapy
    This is the first clinical trial using Cognitive Processing Therapy (CPT) to treat Childbirth-Related Posttraumatic Stress Disorder (CB-PTSD). CPT is considered a frontline treatment for treating PTSD, but has only been applied to treat CB-PTSD in case study format. While CPT is traditionally a 12-session protocol, to make attendance more feasible for a postpartum population, a shortened 8-session protocol will be used (adapted by Gobin, K. C., Boyd, J. E., and Green, S. M). This protocol includ

Primary outcome measures

  • Feasibility: Recruitment Rate [Time frame: Measured through the recruitment period (up to 12 months)]
  • Feasibility: Eligibility Rate [Time frame: Measured through the recruitment period (up to 12 months)]
  • Feasibility: Session Attendance [Time frame: Measured during the treatment period, from the first to last session (up to 8 weeks)]
  • Feasibility: Homework Completion [Time frame: Measured during the treatment period, from the first to last session (up to 8 weeks)]
  • Feasibility: Treatment Completion Rate [Time frame: Measured at the end of treatment (8 weeks)]
  • Feasibility: Retention Rate [Time frame: Measured at baseline (at enrolment, 0 weeks), post-treatment (8 weeks), and one-month follow-up (12 weeks)]
  • Acceptability: measured using a Brief Qualitative Interview [Time frame: Administered one week after finishing the treatment]
  • Acceptability: measured using the Client Satisfaction Questionnaire (CSQ) [Time frame: Administered at post-treatment (immediately after the 8-week intervention)]
Secondary outcome measures (4)
  • The PTSD Checklist for DSM-5 (PCL-5) [Time frame: Administered at baseline (at enrolment), weekly throughout treatment, post-treatment (immediately after the 8 week intervention), and at the 1 month follow-up (one month after intervention completion).]
  • City Birth Trauma Scale (CBTS) [Time frame: Administered at baseline (at enrolment), post-treatment (immediately after the 8 week intervention), and at the 1 month follow-up (one month after intervention completion).]
  • Edinburgh Postnatal Depression Scale (EPDS) [Time frame: Administered at baseline (at enrolment), post-treatment (immediately after the 8 week intervention), and at the 1 month follow-up (one month after intervention completion).]
  • Generalized Anxiety Disorder 7-Item Scale (GAD-7) [Time frame: Administered at baseline (at enrolment), post-treatment (immediately after the 8 week intervention), and at the 1 month follow-up (one month after intervention completion).]

Eligibility criteria

Inclusion criteria

  • women/birthing people aged 18 years and older who are fluent in English (able to speak/understand and read English), and who are at least one month postpartum
  • either indicate clinical levels of PTSD related to a traumatic birth (i.e., 31 or higher on the PCL-5) or endorse significant distress or impairment as a result of their traumatic childbirth experience
  • not receiving concurrent psychological treatment
  • not taking psychoactive medication or if taking medications, are stable in dose and type for at least 8 weeks prior to the study (as per Canadian psychiatric guidelines; McQueen et al., 2016) and remain stable throughout the study

Exclusion criteria

  • severe depression/suicidality requiring acute intervention
  • medication changes in dose or type

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Canada · 1 center
  • Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton — Hamilton

Publications

  • Gobin, K. C., Boyd, J. E., & Green, S. M. (2023). Cognitive Processing Therapy for Childbirth-Related Posttraumatic Stress Disorder: A Case Report. Cognitive and Behavioral Practice, 30(1), 133-145. https://doi.org/10.1016/j.cbpra.2021.12.004

Identifiers

NCT: NCT07495228 · CPT for CB-PTSD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗